Bringing Predictability and Optimization to the Contracting and Budgeting Process in Study Startup
Save your seat!
We look forward to you joining us.
Tuesday, December 11
1 pm ET / 10 am PT
Starting a discussion with sub-steps that matter
For years, this laborious step has ranked as the lengthiest of study startup activities, and recent data suggest it remains the primary cause of site activation failure. Some 50.5% of sponsors and 54.3% of contract research organizations (CROs) cite it as the main culprit.
Measuring these sub-steps is critical to building prediction models that identify processes causing bottlenecks. With a predictive capability, grounded in workflow-based metrics, it becomes possible to condense contract cycle times, presenting a significant opportunity for optimizing clinical trial operations.
As the clinical trials sector continues embracing tools designed to capture contracting and budget cycle time metrics, they can empower intelligence and decision making at the site, sponsor, and CRO levels.
In this webinar, we will explore:
- How granular metrics empower business intelligence, process optimization and efficient resource allocation
- How standardize metrics aid in benchmarking and building predictability models
- How site selection and engagements can be improved with real-time contracting metrics
- The importance of using metrics to have stakeholder discussions on the thorny issues associated with delays and bottlenecks
This webinar is applicable to:
- Sponsor and CRO roles responsible for site identification, feasibility assessment, selection and activation
- Sponsor and CRO roles responsible for collecting trial documentation
- Sponsor and CRO roles responsible for clinical trial agreements/site engagements
- Sponsor and CRO roles responsible for project management of studies and operational excellence
Barry is a clinical trial and operations management expert. His experiences as an Oncology nurse, clinical trial coordinator and his senior management roles at Novartis, Roche, Merck, and AstraZeneca provides him with a well-rounded set of skills and experiences in the clinical trial space. His passion is transforming study management and trial execution processes through the creation of optimized business processes, which are supported by facilitating systems, which allow sponsor and investigator teams to meet their patient and clinical program goals faster and more efficiently.
Head of Business Operations
Joan is the Vice President of Marketing and Strategy at ClinX, a global service solutions provider for research sites, patients and healthcare organizations. Prior to joining ClinX, Joan's 20+ years in the health life sciences industry includes working in senior management roles at SCORR Marketing, CenterWatch, Cambridge Healthtech Institute, Tufts Center for the Study of Drug Development at Tufts University, and PAREXEL International. Joan holds a B.S. in Marketing.
Joan is on the Board of Directors for Greater Gift, The Center for Information and Study on Clinical Research Participation (CISCRP), the US PharmaTimes Steering Committee for CROY, Steering Committee for Pharma Intelligence/Informa Clinical & Research Excellence Awards, Steering Committee for PopUp Star and is an active member of the Association of Clinical Research Professionals (ACRP) and the Drug Information Association (DIA).
VP Marketing and Strategy
ClinX, parent company of ClinEdge
Elvin is a recognized industry expert in clinical trials, having over twenty years of experience working as a Clinical Business Analyst Consultant at major pharmaceutical companies including, Hoffmann-La Roche and Johnson & Johnson. Elvin works as a product strategist and system architect in goBalto’s effort to optimize Study Startup. Elvin is the co-chair on the TMF Reference Model Exchange Mechanism and holds a Master of Science in Industrial Engineering from Aalborg Universitet.
Senior Director, Industry Strategy
Need more information?
Contact us with your questions or to schedule a demo.